Sales Support
U.S.:+1-415-871-0703
U.K.:+44-203-289-4040
AUS.: +61-2-4786-0457
INDIA:+91-848-285-0837
Contact Us
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Paroxysmal Nocturnal Hemoglobinuria Treatment Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026

  • Purchase Options

 

Summary

The global Paroxysmal Nocturnal Hemoglobinuria Treatment Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

Nocturnal hemoglobinuria, also known as paroxysmal nocturnal hemoglobinuria, is an inherited condition that causes the impaired production and insufficient death of red blood cells called hemoglobin. The disease mainly affects white blood cells, which protect the entire body from infection; red blood cells, which carry oxygen to all organs of the body; and platelet, which play a major role in the formation and maintenance of blood clots. Frequent urination, blood in the urine, swelling in the ankles, legs, or feet, fatigue, frequent fever, chills, diarrhea, night sweats, and weight loss are some of the symptoms of paroxysmal nocturnal hemoglobinuria.

The rise in the geriatric population coupled with the rapid adoption of advanced and novel treatment is primarily fueling the market growth of the paroxysmal nocturnal hemoglobinuria (PNH) treatment. Moreover, the increasing prevalence of chronic blood disorder coupled with the advent of biologics is again supporting the market growth.  According to The Johns Hopkins University, PNH affects 1-1.5 persons per million of the population and is primarily a disease of younger adults. The median age of diagnosis is 35-40 years of age, with occasional cases diagnosed in childhood or adolescence. PNH is closely related to aplastic anemia. Favorable legislation and increased adoption of advanced treatment is further projected to propel the market growth of the paroxysmal nocturnal hemoglobinuria (PNH) treatment.

North America is expected to gain significant growth over the forecast period and this is attributed to the high presence of the geriatric population which is increasing prevalence rate. Also, the growing prevalence of such chronic blood-related disorder is again anticipated to augment the regional market growth over the forecast period. According to the Centers for Disease Control and Prevention, Hemophilia A affects 1 in 5,000 male births. About 400 babies are born with hemophilia A each year. The number of people affected by DVT/PE (also called venous thromboembolism) is unknown, although as many as 900,000 people could be affected (1 to 2 per 1,000) each year in the United States.

Key Developments:

  1. In October 2020, Alexion Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved ULTOMIRIS® (ravulizumab-cwvz) 100 mg/mL formulation for the treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH) and for atypical hemolytic uremic syndrome (aHUS).
  2. In December 2018, The FDA approved ravulizumab injection for the treatment of adults with paroxysmal nocturnal hemoglobinuria.
  3. In January 2020, Akari Therapeutics, Plc announces positive interim data from its Phase III PNH CAPSTONE study in complement inhibitor naïve, transfusion-dependent PNH patients.

The Paroxysmal Nocturnal Hemoglobinuria Treatment Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Paroxysmal Nocturnal Hemoglobinuria Treatment Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Achillion Pharmaceuticals Inc
  • Akari Therapeutics Plc
  • Alexion Pharmaceuticals Inc
  • Alnylam Pharmaceuticals Inc
  • Amgen Inc
  • Apellis Pharmaceuticals Inc
  • F. Hoffmann-La Roche Ltd
  • ISU ABXIS Co Ltd
  • Novartis AG
  • NovelMed Therapeutics Inc
  • Omeros Corp
  • Ra Pharmaceuticals Inc
  • Regeneron Pharmaceuticals Inc
  • Regenesance BV

By the Product Type, the market is primarily segmented into:

  • ACH-4471
  • ALN-CC5
  • ALXN-1210
  • AMY-101
  • APL-2
  • Others

By Applications, the market is segmented into:

  • Hospital
  • Clinic
  • Others

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Paroxysmal Nocturnal Hemoglobinuria Treatment Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Paroxysmal Nocturnal Hemoglobinuria Treatment Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Paroxysmal Nocturnal Hemoglobinuria Treatment Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Paroxysmal Nocturnal Hemoglobinuria Treatment Market

The Paroxysmal Nocturnal Hemoglobinuria Treatment Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Paroxysmal Nocturnal Hemoglobinuria Treatment Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Industry Overview of Paroxysmal Nocturnal Hemoglobinuria Treatment
1.1 Definition of Paroxysmal Nocturnal Hemoglobinuria Treatment
1.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment by Type
1.2.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 ACH-4471
1.2.3 ALN-CC5
1.2.4 ALXN-1210
1.2.5 AMY-101
1.2.6 APL-2
1.2.7 Others
1.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment by Applications
1.3.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Overall Market
1.4.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (2014-2025)
1.4.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production (2014-2025)
1.4.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
1.4.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
1.4.5 China Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
1.4.6 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)
1.4.8 India Paroxysmal Nocturnal Hemoglobinuria Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment
2.3 Manufacturing Process Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment
2.4 Industry Chain Structure of Paroxysmal Nocturnal Hemoglobinuria Treatment

3 Development and Manufacturing Plants Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Paroxysmal Nocturnal Hemoglobinuria Treatment
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Production and Capacity Analysis
4.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Analysis
4.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Price Analysis
4.4 Market Concentration Degree

5 Paroxysmal Nocturnal Hemoglobinuria Treatment Regional Market Analysis
5.1 Paroxysmal Nocturnal Hemoglobinuria Treatment Production by Regions
5.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production by Regions
5.1.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Regions
5.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption by Regions
5.3 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
5.3.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Production
5.3.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
5.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
5.4.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Production
5.4.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
5.5 China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
5.5.1 China Paroxysmal Nocturnal Hemoglobinuria Treatment Production
5.5.2 China Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
5.6 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
5.6.1 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Production
5.6.2 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
5.7 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
5.7.1 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Production
5.7.2 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export
5.8 India Paroxysmal Nocturnal Hemoglobinuria Treatment Market Analysis
5.8.1 India Paroxysmal Nocturnal Hemoglobinuria Treatment Production
5.8.2 India Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Paroxysmal Nocturnal Hemoglobinuria Treatment Import and Export

6 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment Market Analysis (by Type)
6.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production by Type
6.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Type
6.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Price by Type

7 Paroxysmal Nocturnal Hemoglobinuria Treatment Segment Market Analysis (by Application)
7.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption by Application
7.2 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption Market Share by Application (2014-2019)

8 Paroxysmal Nocturnal Hemoglobinuria Treatment Major Manufacturers Analysis
8.1 Achillion Pharmaceuticals Inc
8.1.1 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.1.2 Achillion Pharmaceuticals Inc Product Introduction, Application and Specification
8.1.3 Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Akari Therapeutics Plc
8.2.1 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.2.2 Akari Therapeutics Plc Product Introduction, Application and Specification
8.2.3 Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Alexion Pharmaceuticals Inc
8.3.1 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.3.2 Alexion Pharmaceuticals Inc Product Introduction, Application and Specification
8.3.3 Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Alnylam Pharmaceuticals Inc
8.4.1 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.4.2 Alnylam Pharmaceuticals Inc Product Introduction, Application and Specification
8.4.3 Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Amgen Inc
8.5.1 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.5.2 Amgen Inc Product Introduction, Application and Specification
8.5.3 Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Apellis Pharmaceuticals Inc
8.6.1 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.6.2 Apellis Pharmaceuticals Inc Product Introduction, Application and Specification
8.6.3 Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 F. Hoffmann-La Roche Ltd
8.7.1 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.7.2 F. Hoffmann-La Roche Ltd Product Introduction, Application and Specification
8.7.3 F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 ISU ABXIS Co Ltd
8.8.1 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.8.2 ISU ABXIS Co Ltd Product Introduction, Application and Specification
8.8.3 ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Novartis AG
8.9.1 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.9.2 Novartis AG Product Introduction, Application and Specification
8.9.3 Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 NovelMed Therapeutics Inc
8.10.1 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
8.10.2 NovelMed Therapeutics Inc Product Introduction, Application and Specification
8.10.3 NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Omeros Corp
8.12 Ra Pharmaceuticals Inc
8.13 Regeneron Pharmaceuticals Inc
8.14 Regenesance BV

9 Development Trend of Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment Market
9.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trend Analysis
9.1.1 Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Volume and Value) Forecast 2019-2025
9.2 Paroxysmal Nocturnal Hemoglobinuria Treatment Regional Market Trend
9.2.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
9.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
9.2.3 China Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
9.2.4 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
9.2.5 Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
9.2.6 India Paroxysmal Nocturnal Hemoglobinuria Treatment Forecast 2019-2025
9.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trend (Product Type)
9.4 Paroxysmal Nocturnal Hemoglobinuria Treatment Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Paroxysmal Nocturnal Hemoglobinuria Treatment Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures
Figure Picture of Paroxysmal Nocturnal Hemoglobinuria Treatment
Table Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share by Types in 2018
Figure ACH-4471 Product Picture
Figure ALN-CC5 Product Picture
Figure ALXN-1210 Product Picture
Figure AMY-101 Product Picture
Figure APL-2 Product Picture
Figure Others Product Picture
Table Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) (2014-2025)
Figure Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs) (2014-2025)
Figure North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Million USD) (2014-2025)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Million USD) (2014-2025)
Figure China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Million USD) (2014-2025)
Figure Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Million USD) (2014-2025)
Figure Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Million USD) (2014-2025)
Figure India Paroxysmal Nocturnal Hemoglobinuria Treatment Market Size (Million USD) (2014-2025)
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment in 2018
Figure Manufacturing Process Analysis of Paroxysmal Nocturnal Hemoglobinuria Treatment
Figure Industry Chain Structure of Paroxysmal Nocturnal Hemoglobinuria Treatment
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Paroxysmal Nocturnal Hemoglobinuria Treatment Manufacturing Plants Distribution
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs) of Major Manufacturers (2014-2019)
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share of Major Manufacturers (2014-2019)
Figure Paroxysmal Nocturnal Hemoglobinuria Treatment Production Share by Manufacturers in 2018
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share of Major Manufacturers (2014-2019)
Figure Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Share by Manufacturers in 2018
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production by Regions 2014-2019 (K Pcs)
Table Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share by Regions 2014-2019
Figure Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share by Regions in 2018
Table Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue by Regions 2014-2019 (Million USD)
Table Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Regions 2014-2019
Figure Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share by Regions in 2018
Table Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption by Regions 2014-2019 (K Pcs)
Table Global Paroxysmal Nocturnal Hemoglobinuria Treatment Consumption Market Share by Regions 2014-2019
Figure North America Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure North America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table North America Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Consumption Import and Export (K Pcs)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Consumption Import and Export (K Pcs)
Figure China Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure China Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table China Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Consumption Import and Export (K Pcs)
Figure Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Consumption Import and Export (K Pcs)
Figure India Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate 2014-2019 (K Pcs)
Figure India Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate 2014-2019 (Million USD)
Table India Paroxysmal Nocturnal Hemoglobinuria Treatment Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2014-2019)
Figure Global Value (Consumption) Paroxysmal Nocturnal Hemoglobinuria Treatment Market Share by Application (2014-2019)
Table Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table Achillion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table Akari Therapeutics Plc Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table Alexion Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table Alnylam Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table Amgen Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table Apellis Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table ISU ABXIS Co Ltd Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table Novartis AG Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Product Introduction, Application and Specification
Table NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate (2014-2019)
Table NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Market Share (2014-2019)
Figure NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Market Share (2014-2019)
Table NovelMed Therapeutics Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Main Business and Markets Served
Table Omeros Corp Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Ra Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Regeneron Pharmaceuticals Inc Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Table Regenesance BV Paroxysmal Nocturnal Hemoglobinuria Treatment Production Sites and Area Served
Figure Global Paroxysmal Nocturnal Hemoglobinuria Treatment Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Paroxysmal Nocturnal Hemoglobinuria Treatment Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Paroxysmal Nocturnal Hemoglobinuria Treatment Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Paroxysmal Nocturnal Hemoglobinuria Treatment Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Paroxysmal Nocturnal Hemoglobinuria Treatment by Type (2019-2025)
Table Global Consumption (K Pcs) of Paroxysmal Nocturnal Hemoglobinuria Treatment by Application (2019-2025)
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Distributors List
Table Paroxysmal Nocturnal Hemoglobinuria Treatment Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

 

  • Purchase Options

  • Happy To Assist You

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.

Contact us